Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 25, 2012 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma Announces Year End Results and Corporate Reorganization

LAVAL, Quebec, May 25, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (TSX-V:APO), a Neptune Technologies & Bioressources Inc's ("Neptune") subsidiary, reports the...
March 06, 2012 08:00 ET | Source: Acasti Pharma Inc.

Acasti to Present at The Annual Roth Conference and Grants Incentive Stock Options

LAVAL, Quebec, March 6, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX-V:APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, announces it will be presenting at...
February 13, 2012 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma Closes $2,000,000 CDN Private Placement

LAVAL, Quebec, Feb. 13, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX-V:APO) announces that further to its news release dated February 7, 2012, it has closed a private placement pursuant...
February 07, 2012 11:52 ET | Source: Acasti Pharma Inc.

Acasti Pharma Announces a Private Placement Financing of Approximately $2,000,000 CDN

LAVAL, Quebec, Feb. 7, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX-V:APO) announces it has received from Dr. Harlan Waksal, Acasti's Executive Vice-President, Business &...
January 17, 2012 08:01 ET | Source: Acasti Pharma Inc.

Acasti Pharma Reports Third Quarter Results

LAVAL, Quebec, Jan. 17, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti") (TSX.V:APO), a Neptune Technologies & Bioressources Inc's ("Neptune") subsidiary, today report its financial results for...
January 09, 2012 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma to Present at OneMedForum Conference

LAVAL, Quebec, Jan. 9, 2012 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX-V:APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, announces it will present at the 2012...
December 07, 2011 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma to Present at The American Academy of Anti-Aging Medicine (A4M) and to The American Academy of Private Physicians

LAVAL, Quebec, Dec. 7, 2011 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX-V:APO), a Neptune Technologies & Bioressources Inc. (Neptune) subsidiary, announces that it will be participating...
December 05, 2011 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma Announces the Initiation of a Second Phase II Clinical Study and Consolidation of Its IP Position

LAVAL, Quebec, Dec. 5, 2011 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Acasti) (TSX-V:APO), a subsidiary of Neptune Technologies & Bioressources Inc. (Neptune), announces the extension of...
October 17, 2011 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma Inc. Receives Health Canada Clearance for an Open-Label Phase II Hypertriglyceridemia Trial

LAVAL, Quebec, Oct. 17, 2011 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Acasti) (TSX.V:APO), a subsidiary of Neptune Technologies & Bioressources Inc. (Neptune), has received another positive...
October 14, 2011 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma Reports Second Quarter Results

LAVAL, Quebec, Oct. 14, 2011 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti") (TSX-V:APO), a Neptune Technologies & Bioressources Inc's ("Neptune") subsidiary, today report its financial results for...